Clinical Trial Update: The POWER Trial: Personalised Dose Optimisation With Adjuvant Tamoxifen Therapy in Breast cancER [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial named POWER is investigating personalised dose optimisation of adjuvant tamoxifen therapy for breast cancer. It is currently not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: Karolinska Institutet | Conditions: Breast Cancer, Adjuvant Drug Therapy | Phase 3 | Status: NOT_YET_RECRUITING